Eaton’s Vehicle Group Facilities Aim to Minimize Environmental Impact With New Technologies and Systems
15.10.2020 16:00:00 EEST | Business Wire | Press release
Power management company Eaton today announced its Vehicle Group is installing a variety of sustainable technologies, including energy efficient lighting systems, water conservation equipment and energy-generating solar panels, at its global manufacturing facilities to reduce the company’s environmental footprint.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201015005246/en/
Eaton’s Vehicle Group site in Jining, China, installed a solar roof to generate electricity for the facility. (Photo: Business Wire)
Reducing water consumption and pollutants
To reduce water consumption and mitigate pollutants, Eaton’s Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies for the treatment of industrial process water at several of its facilities. The systems are designed to treat and reuse water for industrial purposes.
In addition, some facilities are managing their stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion, and adding native plantings that don’t require watering.
Employees at Vehicle Group’s Valinhos, Brazil, facility initiated an innovative water conservation system that treats water used at the plant with physicochemical and biological processes. The treated water is then reused in restrooms and for cleaning. In the first month of operation the system saved 40 cubic meters of water and is projected to increase to 129 cubic meters of water savings per month as the process is refined.
Multiple Vehicle Group sites also have made progress in diverting grinding swarf waste from landfills. Swarf, a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media, is one of the most difficult waste streams to recycle. Through vendor partnerships, the Vehicle Group deployed a mobile centrifuge process that separates the materials, making it possible to reuse the fluid during manufacturing processes and recycle the metal particles.
Leveraging innovative technologies to reduce energy consumption
New lighting systems composed entirely of light-emitting diodes (LEDs), which utilize 70 percent less energy than traditional lighting technologies, are being added at Eaton’s Vehicle Group facilities. The LEDs are activated by motion sensors that detect when someone enters or exits an area and a wireless control system that manages every lighting fixture and tracks the status of each. The Vehicle Group’s Tczew, Poland, facility recently installed such a system and has already realized a large reduction in energy consumption resulting in savings of hundreds of dollars in monthly costs.
Many of the electrical systems within a facility are sourced from Eaton’s Electrical Sector, a global leader in power distribution, power quality, industrial automation and power control product and service solutions.
In addition to leveraging LEDs, some Vehicle Group sites are taking steps to produce their own power by installing massive solar panels on the roof. A 10,000-square-meter solar panel array was recently installed on the rooftop of the Vehicle Group’s Wuxi, China, facility, and it’s expected to generate 769 MWh of electrical power annually. Electricity generated will be used for manufacturing at the plant, reducing greenhouse gases by about 588 tons per year. Additionally, solar roofs were installed in the Nashik and Ranjangaon, India, plants, reducing more than a 1,000 tons of carbon dioxide emissions annually.
Constructed from the ground up with an environmental focus
The manufacturing facility in Aguascalientes, Mexico, was constructed with a number of new environmentally focused features, including motorized windows for natural ventilation, reflective roofs for low solar gain and a daylight harvesting system that uses natural light to minimize energy consumption.
The site features a lighting system composed entirely of LEDs, a cooling system with motorized windows for natural ventilation and a reflective roof to reduce heat detention, while dryers and a mist eliminator ensure quality air flows through the plant.
Driving the movement toward a circular economy
Eaton is joining the global movement to mitigate climate change, which includes science-based targets for cutting carbon emissions from the company’s operations by at least 50 percent by 2030, positioning Eaton to achieve carbon neutrality.
Eaton’s eMobility business is contributing to a carbon-free future by installing vehicle charging ports for electrified vehicles at all its global sites, which encourages employees to choose zero-emission cars for their workplace commute.
In an effort to reduce waste, Eaton also is committed to achieving zero waste-to-landfill (ZWTL) status at 100 percent of its manufacturing facilities by 2030, and the Vehicle Group is doing its part to contribute to this important effort. Eaton’s Vehicle Group continues to implement ZWTL initiatives at its sites around the world. In 2020, its Hastings, Nebraska, facility was added to its list of manufacturing sites that are zero waste-to-landfill certified, bringing the global Vehicle Group sites that are ZWTL compliant to 74 percent.
“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities in a way that improves energy efficiency, minimizes the impact on the environment, and brings us closer to a carbon-free future,” said João Faria, president, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”
Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.
Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.
Eaton’s mission is to improve the quality of life and the environment through the use of power management technologies and services. We provide sustainable solutions that help our customers effectively manage electrical, hydraulic, and mechanical power – more safely, more efficiently, and more reliably. Eaton’s 2019 revenues were $21.4 billion, and we sell products to customers in more than 175 countries. We have approximately 92,000 employees. For more information, visit www.eaton.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201015005246/en/
Contact information
Thomas Nellenbach
thomasjnellenbach@eaton.com
(216) 333-2876 (cell)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
